Jeff
Analyst
Citi (on behalf of Ron Josey)
Equibles does not estimate personal net worth.
About Jeff
Jeff is recorded as Analyst at Citi (on behalf of Ron Josey). Jeff has spoken on 2 earnings calls and 5 other investor events across 7 companies, most recently for American Homes 4 Rent on September 16, 2026. Those appearances were for American Homes 4 Rent (AMH), Apogee Therapeutics, Inc., Cytokinetics Inc (CYTK), Reckitt Benckiser Group PLC (RBGLY), Pure Cycle Corp (PCYO) and 2 other companies. The companies whose calls Jeff spoke on are classified in the Real Estate, Healthcare, Consumer Defensive and Utilities sectors.
Jeff on recent calls
“So, just to confirm you, does this tie to your sentence you said, or statement, we now have clarity? I just want to make sure, have you fleshed that out completely, or is there anything else to, you know, elaborate on?”
“I think first, when you look at SkyRizzy's launch, right, they launched into, I would say, a much more competitive market of plaque psoriasis from a biologic perspective versus what we'll be launching into in AD.”
“I mean, with the new news, we've had a lot of, you know, just a lot of excitement from customers.”
“So thank you everyone for coming along this morning and thank you for enjoying the fine Scottish weather that we have today in Paris. I'm delighted to introduce Chris Licht, who I'm sure many of you know well.”
“As I recall, you were going to wait for the commercial development until the interchange was actually finished. Did I understand that you're currently actively marketing the commercial opportunities?”
Affiliation history
-
Citi (on behalf of Ron Josey)
Analyst
Source not stated
Current
Company network
Apogee Therapeutics, Inc.
Biotechnology · Healthcare
CYTK
Biotechnology · Healthcare
Household & Personal Products · Consumer Defensive
PCYO
Utilities - Regulated Water · Utilities
SPGI
Financial Data & Stock Exchanges · Financial Services
COMP
Real Estate Services · Real Estate
Recent activity
-
-
-
Conference
Jefferies Global Healthcare Conference
Apogee Therapeutics, Inc.
-
-
-
-